Compounds of general formula (I), their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical compositions comprising said compounds, and methods of treating diseases with said compounds.
通式(I)化合物,其作为
钙受体活性化合物用于预防、治疗或改善与CaSR活性紊乱相关的生理障碍或疾病,如甲状旁腺功能亢进症,包括所述化合物的制药组合物和使用所述化合物治疗疾病的方法。